[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10475-10476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03620]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-589]
Importer of Controlled Substances Application: PerkinElmer, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before March 25, 2020. Such
persons may also file a written request for a hearing on the
application on or before March 25, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug
[[Page 10476]]
Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on January 13, 2020, PerkinElmer, Inc., 120 E Dedham
Street, Boston, Massachusetts 02118-2852 applied to be registered as an
importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide......... 7315 I
Thebaine........................... 9333 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
bulk for manufacturing wherein the controlled substances will be
labeled with a radioactive tracer compound and sold for research
purposes to its customers. Thebaine (9333) will be used to manufacture
the derivative Diprenorphine.
Dated: January 31, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-03620 Filed 2-21-20; 8:45 am]
BILLING CODE 4410-09-P